Table of Contents Table of Contents
Previous Page  1237 / 1578 Next Page
Information
Show Menu
Previous Page 1237 / 1578 Next Page
Page Background

/

Study # events

OAR

definition

Dose in patients with

radiation myelopathy Conclusion

Ryu

2006

1 / 177

SC 6mm CC

of TV

9.6Gy to 10%

10% < 10Gy

Gibbs

2009

6 / 1075

NS

D

max

8.5 – 26.2Gy

1cm

3

< 8Gy

Sahgal

2010

5 / 24

case control study

Thecal sack

D

max

median 59Gy (nBED

2/2

)

D

max

below

thresholds using

LQ model

Safety of spine SBRT: myelopathy

• (Very) Few patients developed radiation induced myelopathy

• Dose – response inconclusive

• However: follow-up short in majority of patients

ESTRO SBRT 2017 - Matthias Guckenberger

15

07.09.17

/

Safety of spine SBRT: myelopathy

Multi-institutional analysis:

• 9 cases with radiation induced myelopathy

• 66 cases w/o radiation induced myelopathy

Sahgal IJROBP 2012

1 fraction 3 fractions 5 fractions

1%probability

9.2

14.8

18.2

2%probability

10.7

17.4

21.5

3%probability

11.5

18.8

23.1

4%probability

12

19.6

24.4

5%probability

12.4

20.3

25.3

• Doses converted to 2Gy equivalent dose (EQD2/2)

• Dmax to thecal sack

• LARGE confidence intervals

ESTRO SBRT 2017 - Matthias Guckenberger

16

07.09.17